Meeting link: https://www.actox.org/am/am2022/
Don’t miss the overview of CT-TRACS’ Advanced Sequencing project, presented by committee co-chair Dr. Mick Fellows, with a talk entitled: “Assessment of CRISPR-Cas9 Induced Off-Target Mutagenesis in Gene-Edited Cellular Therapeutics (Induce-Seq + DS): A HESI CT-TRACS Supported Project”.
The presentation is part of Symposium # 3, “Applications for Duplex Sequencing of DNA in Genetic Toxicology: A Sneak Peek into the Future of Hazard Identification and Risk Assessment” which will be held on Monday Nov. 14th, 9:00-12:00 MST.
Abstract available at https://www.actox.org/am/am2022/symposia.asp: see abstract #3-4
If you are on site, be sure to connect with Dr. Fellows for more information about the project; or contact HESI staff anytime: Lucilia Mouriès at email@example.com.
Drs. Anthony Lynch (GSK) and Andres Czich (Sanofi) will be giving a talk entitled “The HESI Nitrosamine Subgroup: Overview and update on activities” during Workshop 4 “Addressing the Global Challenge of Nitrosamine Impurities in Pharmaceutical Products”. This workshop will take place on Monday November 14 from 2:00 – 5:00 MST.